Mirum Pharmaceuticals, Inc. (MIRM) Net income 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$23.4MFY2025 · since FY2019: -$52.6M → -$23.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.4M | +73.4% |
| FY2024 | -$87.9M | +46.2% |
| FY2023 | -$163.4M | -20.5% |
| FY2022 | -$135.7M | -61.5% |
| FY2021 | -$84.0M | +18.7% |
| FY2020 | -$103.3M | -96.5% |
| FY2019 | -$52.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MIRM financial trends
MIRM RevenueMIRM Net marginMIRM Gross profitMIRM Gross marginMIRM Operating incomeMIRM Operating marginMIRM Operating cash flowMIRM Free cash flowMIRM Capital expendituresMIRM Return on equityMIRM Stock buybacksMIRM Dividends paidMIRM Total assetsMIRM Total liabilitiesMIRM Shareholders’ equityMIRM overview →